Haleon’s Supplier Hub for Sustainable Supply Chains – Healthcare Digital

Haleon’s Strategic Initiative to Advance Sustainable Development Goals

Introduction to the Supplier Sustainability Hub

Global consumer healthcare company Haleon has launched a digital supplier hub designed to facilitate and advance the sustainability efforts of its supply chain partners. This platform is a core component of Haleon’s strategy to achieve its internal environmental targets by fostering a collaborative ecosystem focused on shared sustainability objectives.

Alignment with Key Sustainable Development Goals (SDGs)

1. SDG 13: Climate Action
   • The initiative directly targets climate action by providing resources for decarbonisation across Haleon’s entire value chain.
   • It specifically addresses Scope 1, 2, and 3 emissions, demonstrating a comprehensive approach to reducing the company’s carbon footprint.
2. SDG 12: Responsible Consumption and Production
   • The supplier hub promotes sustainable production patterns by encouraging and enabling partners to adopt more environmentally responsible practices.
   • This aligns with Haleon’s commitment to ensuring sustainability throughout the lifecycle of its products, from sourcing to consumer.
3. SDG 17: Partnerships for the Goals
   • The platform exemplifies a partnership-driven approach, uniting Haleon and its diverse network of suppliers to achieve common sustainability goals.
   • By sharing resources and knowledge, Haleon is strengthening global partnerships for sustainable development.
4. SDG 3: Good Health and Well-being
   • This initiative supports Haleon’s primary mission to improve everyday health. The company’s focus on responsible practices includes addressing environmental and social barriers that can impede access to quality healthcare, reinforcing its contribution to global well-being.

Corporate Profile and Commitment

• Haleon is a prominent British pharmaceutical and consumer healthcare business, formed in 2022 from divisions of GSK, Novartis, and Pfizer.
• With a portfolio including brands like Sensodyne, Panadol, and Advil, the company’s products are available in 170 countries.
• The launch of the supplier hub underscores Haleon’s operational focus on responsible business practices as a foundational element of its mission to deliver better everyday health with humanity.

Analysis of Sustainable Development Goals in the Article

1. Which SDGs are addressed or connected to the issues highlighted in the article?

• SDG 3: Good Health and Well-being: The article states that Haleon’s core mission is to “improve everyday healthcare for consumers” and address “social barriers that can impede access to quality healthcare.” This directly aligns with the goal of ensuring healthy lives and promoting well-being.
• SDG 12: Responsible Consumption and Production: The launch of a supplier hub to “help its suppliers advance their sustainability efforts” and encourage partners to adopt sustainable goals is a clear initiative towards ensuring sustainable consumption and production patterns throughout the value chain.
• SDG 13: Climate Action: The article explicitly mentions Haleon’s strategy to meet its “environmental targets” by addressing “Scope 1, 2 and 3 emissions” to “ensure decarbonisation across its full value chain.” This is a direct action to combat climate change and its impacts.
• SDG 17: Partnerships for the Goals: The creation of a “supplier hub” is a partnership-based approach. Haleon is collaborating with its suppliers by providing a “digital platform” and “shared resources” to collectively achieve sustainability goals, which embodies the spirit of strengthening the means of implementation and revitalizing global partnerships.

2. What specific targets under those SDGs can be identified based on the article’s content?

1. Target 3.8: Achieve universal health coverage, including access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines. Haleon’s work in making its consumer healthcare brands like Panadol and Advil “available across 170 countries” contributes to this target by improving access to essential healthcare products.
2. Target 12.6: Encourage companies, especially large and transnational companies, to adopt sustainable practices and to integrate sustainability information into their reporting cycle. As a prominent global business, Haleon’s initiative to create a supplier hub and promote sustainability throughout its value chain is a direct implementation of this target.
3. Target 13.2: Integrate climate change measures into policies, strategies and planning. Haleon is integrating climate action into its corporate strategy by setting “environmental targets” and implementing a plan for “decarbonisation across its full value chain.”
4. Target 17.17: Encourage and promote effective public, public-private and civil society partnerships. The supplier hub is a form of private-private partnership where Haleon collaborates with its supplier network to “advance their sustainability efforts” through shared knowledge and resources.

3. Are there any indicators mentioned or implied in the article that can be used to measure progress towards the identified targets?

1. Implied Indicator for Target 3.8: The article mentions that Haleon’s brands are “available across 170 countries.” The proportion of the population covered by essential healthcare products can be seen as an implied indicator of progress towards universal health access.
2. Implied Indicator for Target 12.6: The launch and adoption of the “new supplier hub” itself is an indicator. The number of suppliers engaged with the platform and adopting sustainable practices would be a way to measure the progress of this initiative.
3. Mentioned Indicator for Target 13.2: The article explicitly refers to “Scope 1, 2 and 3 emissions.” The reduction of these greenhouse gas emissions is a direct and measurable indicator used to track progress on decarbonization and climate action strategies.
4. Implied Indicator for Target 17.17: The existence and functionality of the “digital platform” as a shared resource for suppliers is an indicator of a partnership in action. The volume of “shared resources” accessed or the number of collaborative projects initiated through the hub could measure the partnership’s effectiveness.

4. Create a table with three columns titled ‘SDGs, Targets and Indicators” to present the findings from analyzing the article.

Source: healthcare-digital.com